DOJ Granted Leave To Join High Court Arguments Over Patent On-Sale Dates

Mealey's (October 10, 2018, 11:32 AM EDT) -- WASHINGTON, D.C. — The same day that Teva Pharmaceuticals USA Inc. filed its respondent brief in a U.S. Supreme Court dispute over what triggers the on-sale bar in the patent application...
To view the full article, register now.